MétaCan
Menu
Back to cohort
Record W2033352338 · doi:10.1093/ndtplus/sfp032

Comment on: 'Lanthanum carbonate possibly responsible for acute liver failure in a patient with Child-Pugh stage A liver cirrhosis'

2009· article· en· W2033352338 on OpenAlexaff
Michael Smyth, Bálint Gellért, Raymond Pratt

Bibliographic record

VenueClinical Kidney Journal · 2009
Typearticle
Languageen
FieldMedicine
TopicParathyroid Disorders and Treatments
Canadian institutionsGlobal Affairs Canada
Fundersnot available
KeywordsLanthanum carbonateMedicineDecompensationLiver diseaseCirrhosisGastroenterologyLorazepamAlcoholic liver diseaseInternal medicinePediatricsHyperphosphatemiaPsychiatryKidney disease

Abstract

fetched live from OpenAlex

Sir, De Leeuw and colleagues reported decompensation of existing liver disease in a patient with a complex history including alcohol-induced liver cirrhosis, pancreatitis and secondary diabetes [1]. The patient required hospitalization due to decreased consciousness and somnolence. The authors, noting a temporal association with lanthanum carbonate therapy, proposed that there was a causal relationship. This patient report is highly confounded by a number of factors, including concomitant medication and hypophosphataemia, which are also credible explanations for the patient's presentation. Firstly, the patient was taking lorazepam, which can cause coma in patients with reduced hepatic metabolism. Secondly, following dialysis the patient was profoundly hypophosphataemic. This is a recognized cause of irritability, paraesthaesia, confusion, convulsions and coma [2]. Evaluation of the published data on lanthanum carbonate (FOSRENOL®, Shire Pharmaceuticals, Basingstoke, UK) shows that the bioavailability is ∼0.001% and the small fraction of lanthanum absorbed is not metabolized. Animal studies have demonstrated that the presence of lanthanum in the liver is consistent with hepatic excretion via a lysosomal transcellular transport mechanism [3,4]. A long-term follow-up of clinical trial cohorts has included liver function tests and has not demonstrated any evidence of acute or chronic liver toxicity during 2 years of therapy compared to standard therapy. In uncontrolled studies, subjects have been exposed to lanthanum carbonate for up to 6 years [5,6]. In addition to over 5000 subjects in clinical studies, there is now over 60000 patient-years of post-marketing experience with lanthanum carbonate. Although no specific studies were done in patients with liver impairment, there is insufficient evidence to assume that lanthanum carbonate may contribute to a worsening of liver function in this patient population. Conflict of interest statement. M.S., B.G. and R.D.P. are employees of Shire Pharmaceuticals. Editorial Note: Dr De Leeuw et al. had been invited to reply to this letter but we did not receive a response in time.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.015
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Commentary · Consensus signal: Commentary
Teacher disagreement score0.029
Threshold uncertainty score0.019

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.015
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0010.002
Scholarly communication0.0010.003
Open science0.0030.001
Research integrity0.0290.020
Insufficient payload (model declined to judge)0.0060.004

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.029
GPT teacher head0.350
Teacher spread0.320 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2009
Admission routes1
Has abstractyes

Explore more

Same venueClinical Kidney JournalSame topicParathyroid Disorders and TreatmentsFrench-language works237,207